Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 5
Submit an article Journal homepage
471
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia

Xueyan Chena Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
,
Megan Othusb Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
,
Brent L. Wooda Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
,
Roland B. Walterb Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;c Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA
,
Pamela S. Beckerb Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;c Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA
,
Mary-Elizabeth Percivalb Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;c Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA
,
Janis L. Abkowitzc Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USA
,
Frederick R. Appelbaumb Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
&
Elihu H. Esteyb Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;c Division of Hematology/Department of Medicine, University of Washington, Seattle, WA, USACorrespondence[email protected]
 show all
Pages 1226-1233 | Received 04 Jul 2020, Accepted 29 Nov 2020, Published online: 19 Dec 2020

References

  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2017.
  • DeLima M, Albitar M, O’Brien S, et al. Comparison of referring and tertiary cancer center physician’s diagnoses in patients with leukemia. Am J Med. 1998;104(3):246–251.
  • Naqvi K, Jabbour E, Bueso-Ramos C, et al. Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers. Blood. 2011;118(17):4690–4693.
  • Lindsley RC, Mar BG, Mazzola E, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;125(9):1367–1376.
  • Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 2003;21(24):4642–4649.
  • Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
  • Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–2465.
  • Flach J, Dicker F, Schnittger S, et al. An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling. Leukemia. 2011;25(4):713–718.
  • Ley TJ, Miller C, Ding L, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059–2074.
  • Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28(2):241–247.
  • Papaemmanuil E, Gerstung M, Malcovati L, et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122(22):3616–3627.
  • Walter MJ, Shen D, Shao J, et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia. 2013;27(6):1275–1282.
  • Corces-Zimmerman MR, Hong WJ, Weissman IL, et al. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci USA. 2014;111(7):2548–2553.
  • Estey E, Thall P, Beran M, et al. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy. Blood. 1997;90(8):2969–2977.
  • Bernstein SH, Brunetto VL, Davey FR, et al. Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a cancer and leukemia group B study. J Clin Oncol. 1996;14(9):2486–2494.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.